E
Aadi Bioscience, Inc. AADI
$2.11 -$0.0105-0.50%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 3/14/2023Downgrade
Aadi Bioscience, Inc. (AADI) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell 3/3/2023Downgrade
Aadi Bioscience, Inc. (AADI) was downgraded to D- from D on 3/3/2023 due to a decline in the volatility index and total return index.
D
Sell 2/9/2023Upgraded
Aadi Bioscience, Inc. (AADI) was upgraded to D from E+ on 02/09/2023.
E
Sell 2/8/2023Downgrade
Aadi Bioscience, Inc. (AADI) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index.
D
Sell 12/16/2022Upgraded
Aadi Bioscience, Inc. (AADI) was upgraded to D from D- on 12/16/2022 due to an increase in the volatility index and total return index.
D
Sell 12/1/2022Downgrade
Aadi Bioscience, Inc. (AADI) was downgraded to D- from D on 12/1/2022 due to a decline in the volatility index.
D
Sell 11/11/2022Upgraded
Aadi Bioscience, Inc. (AADI) was upgraded to D from D- on 11/11/2022 due to a substantial increase in the growth index. Operating cash flow increased 23.55% from -$10.72M to -$8.2M, total revenue increased 23.51% from $3.44M to $4.25M, and earnings per share increased from -$0.8712 to -$0.6805.
D
Sell 5/2/2022Upgraded
Aadi Bioscience, Inc. (AADI) was upgraded to D- from E+ on 5/2/2022 due to an increase in the volatility index.
E
Sell 5/1/2022Upgraded
Aadi Bioscience, Inc. (AADI) was upgraded to E+ from E on 5/1/2022 due to a large increase in the solvency index and growth index. Earnings per share increased from -$9.1733 to -$0.7654, and operating cash flow increased 28.46% from -$17.37M to -$12.43M.
E
Sell 2/1/2022Upgraded
Aadi Bioscience, Inc. (AADI) was upgraded to E from E- on 2/1/2022 due to an increase in the valuation index.
E
Sell 12/30/2021Downgrade
Aadi Bioscience, Inc. (AADI) was downgraded to E- from E on 12/30/2021 due to a decline in the total return index, volatility index and valuation index.
E
Sell 12/15/2021Upgraded
Aadi Bioscience, Inc. (AADI) was upgraded to E from E- on 12/15/2021 due to a noticeable increase in the total return index, volatility index and valuation index.
E
Sell 11/24/2021Downgrade
Aadi Bioscience, Inc. (AADI) was downgraded to E- from E on 11/24/2021 due to a decline in the volatility index.
E
Sell 11/19/2021None
Aadi Bioscience, Inc. (AADI) was downgraded to E from U on 11/19/2021.
Weiss Ratings